OMRON Healthcare's Milestone: Over 400 Million Blood Pressure Monitors Sold
OMRON Healthcare Co., Ltd. has announced a significant milestone in its history: it has surpassed 400 million units of blood pressure monitors (BPMs) sold globally. This remarkable achievement is indicative of the company's dedication to enhancing health longevity through the promotion of home blood pressure monitoring and preventive cardiovascular care.
The journey began more than fifty years ago when OMRON launched its first blood pressure monitor in 1973, a time when such measurements were typically carried out in medical facilities. Today, thanks to advances in technology, individuals can monitor their blood pressure easily and accurately from the comfort of their homes. OMRON Healthcare continues to enhance blood pressure management, including efforts to detect potentially life-threatening conditions such as Atrial Fibrillation (AFib) at an early stage.
With a new chapter unfolding, OMRON's industry-leading devices and digital health platforms are transforming daily monitoring into a powerful tool for safeguarding global health. With a presence in over 130 countries and regions worldwide, OMRON Healthcare is committed to ensuring that access to precise, affordable home blood pressure monitors is available, particularly in developing areas where healthcare resources remain limited. The company aims to reduce health inequalities by facilitating early detection and intervention among the most at-risk populations.
"Reaching 400 million units sold is more than just a number—it signifies the trust millions of people place in OMRON Healthcare to help them live longer, healthier lives," stated Ayumu Okada, President and CEO of OMRON HEALTHCARE Co., Ltd. Medical professionals worldwide recognize the quality and accuracy of OMRON's blood pressure monitors. The company continues to pursue its vision of "Going for ZERO," aiming to prevent catastrophic cardiovascular events globally by developing technologies that bridge daily living and healthcare, empowering people everywhere to take preventive measures.
OMRON will continue to promote innovative products, services, and educational initiatives to raise awareness about the risks of high blood pressure—not only among those already diagnosed but also for individuals who may unknowingly be at risk.
Innovations in Preventive Healthcare
Leveraging over 50 years of experience, OMRON Healthcare is at the forefront of developing technologies that make blood pressure monitors essential tools for health maintenance. Notable innovations include:
- - Connected Digital Health Monitoring: Bluetooth-enabled devices integrate with the OMRON connect™ app, supporting trend visualization, family sharing, and monitoring by physicians.
- - AI-Powered Detection: The FDA-approved Intellisense AFib™ technology enables early detection of Atrial Fibrillation during routine monitoring.
- - Integrated Measurement: The Complete™ monitor combines blood pressure and ECG measurements, which can be seamlessly shared with doctors via the OMRON connect™ app.
- - Remote Monitoring Partnerships: Following the acquisition of the new subsidiary Luscii and strategic collaborations with international companies, OMRON's Digital Health division continues to expand.
For additional information, visit
OMRON Healthcare.
In summary, OMRON Healthcare’s extensive reach and innovations exemplify its unwavering commitment to advancing preventive health measures and improving the quality of life for individuals worldwide through reliable blood pressure monitoring.